SG

Sabi George

Active Director Director DIN 01537147
DIN 01537147 First appointment Jan 2000 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2000
Shareholding value •••• Premium profile

About Sabi George

Data last updated:

Sabi George is a Director at Chalakudy Priya Pharma Private Limited (since 2000). The company operates in Pharma. Chalakudy Priya Pharma Private Limited reported revenue of ₹42.40 Cr (FY 2025).

DIN 01537147
Primary Designation Director
Industry Pharma
First Appointment 24 Jan 2000
Oldest Company Age 29 yrs
Largest company Chalakudy Priya Pharma Private Limited · ₹42.40 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Jan 20001997₹42.40 Cr (FY 2025)Active

Board colleagues of Sabi George

Directorship timeline

Open interactive timeline →
Chalakudy Priya Pharma Private Limited
Premium access

Shareholding and investment profile for Sabi George

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sabi George

Sabi George currently holds 1 directorship: Chalakudy Priya Pharma Private Limited (Director, since 24 Jan 2000, revenue ₹42.40 Cr (FY 2025)).

Sabi George was first appointed on 24 Jan 2000 as Director at Chalakudy Priya Pharma Private Limited.

The current boards of Sabi George's companies include Thomana Mathew George (Chalakudy Priya Pharma Private Limited), Thommana George Jijo (Chalakudy Priya Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available